Alterations in the synthesis of extracellular matrix components including type I collagen occur in a number of fibrotic diseases such as scleroderma, ostearithritis as well as osteoporosis. Studies of the regulatory mechanisms which control the expression of the two type I collagen genes are critical to understand these alterations. In most physiological and pathological conditions, the expression of the alpha1(I) and alpha2(I) collagen genes are coordinately expressed. This coordinate regulation can be explained by the interaction of DNA-binding proteins with common cis-acting elements in the promoter region of both genes. One sequence specific DNA-binding protein that binds similar cis-acting elements located at approximately the same distance from the transcriptional start site in the promoter regions of the alpha1(I) and alpha2(I) mouse collagen genes, has been purified to homogeneity. This factor acts as a transcriptional inhibitor and is called Inhibitory Factor 2 (IF-2). IF-2, a metallo protein that requires zinc ions to bind to DNA, is present in a large variety of cells and presumably participates in the control of expression of several genes. We propose to purify IF-2 to homogeneity, to obtain amino-acid sequences for this protein and to clone cDNAs corresponding to the factor. We will use the purified bacterially expressed protein to generate polyclonal antibodies against IF-2. Using the purified protein and the cDNA clone we plan to perform, at a later time, a structure-function analysis of the molecule, to study the molecular mechanism of transcriptional repression by this transcription factor. We expect that the characterization of transcription factors like IF-2 and the molecular studies of its function win increase understanding of the mechanisms which control the expression of the type I collagen genes in physiological situations and in pathological situations and probably other genes and will bring new information about the regulatory mechanisms used by eukaryotic cells to synthesize specialized proteins.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29AR041059-02
Application #
3457591
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1992-05-01
Project End
1997-04-30
Budget Start
1993-05-01
Budget End
1994-04-30
Support Year
2
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
Other Domestic Higher Education
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Helder, M N; Karg, H; Bervoets, T J et al. (1998) Bone morphogenetic protein-7 (osteogenic protein-1, OP-1) and tooth development. J Dent Res 77:545-54
Zhang, R; Ducy, P; Karsenty, G (1997) 1,25-dihydroxyvitamin D3 inhibits Osteocalcin expression in mouse through an indirect mechanism. J Biol Chem 272:110-6
Karsenty, G; Luo, G; Hofmann, C et al. (1996) BMP 7 is required for nephrogenesis, eye development, and skeletal patterning. Ann N Y Acad Sci 785:98-107
Galera, P; Park, R W; Ducy, P et al. (1996) c-Krox binds to several sites in the promoter of both mouse type I collagen genes. Structure/function study and developmental expression analysis. J Biol Chem 271:21331-9
Ducy, P; Geoffroy, V; Karsenty, G (1996) Study of osteoblast-specific expression of one mouse osteocalcin gene: characterization of the factor binding to OSE2. Connect Tissue Res 35:7-14
Karsenty, G; Park, R W (1995) Regulation of type I collagen genes expression. Int Rev Immunol 12:177-85
Ducy, P; Karsenty, G (1995) Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol Cell Biol 15:1858-69
Desbois, C; Karsenty, G (1995) Osteocalcin cluster: implications for functional studies. J Cell Biochem 57:379-83
Luo, G; Hofmann, C; Bronckers, A L et al. (1995) BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev 9:2808-20
Geoffroy, V; Ducy, P; Karsenty, G (1995) A PEBP2 alpha/AML-1-related factor increases osteocalcin promoter activity through its binding to an osteoblast-specific cis-acting element. J Biol Chem 270:30973-9

Showing the most recent 10 out of 14 publications